CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 2,430 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05431621
NCT05431621N/ACompleted

Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers

Shanghai Zhongshan Hospital·observational·Posted Jun 24, 2022·Updated Jan 29, 2025

In Brief

An observational study for Esophageal Cancer and 3 related conditions. Completed, enrolled 2,430 participants across 4 sites.

Detailed Summary

This is a single blind, case control, multicenter study jointly developed by Zhongshan Hospital of Fudan University, Shanghai Public Health Clinical Center, Shanghai Xuhui Central Hospital, Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, and Shanghai Singlera Genomics Company. The enrolled population will include positive group, precancerous lesions and healthy control group, which is expected to enroll 2,430 participants. The primary objective is to establish molecular testing methods for non-invasive screening and early diagnosis of digestive system cancers through ctDNA methylation and mutation, cfDNA and ctDNA fragment size, and end motif based model (for esophageal, gastric, colorectal cancer), and through ctDNA methylation detection, ctDNA low-pass WGS, miRNA7 and CTC detection and analysis technology based model (for hepatocellular carcinoma). The sensitivity and specificity of the models in cancer early detection will be evaluated.

Study Details

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedJun 24, 2022
Enrollment StartNov 15, 2020
Primary CompletionJun 30, 2023
Study CompletionJul 31, 2023
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 4.0 years ago